Abstract
Purpose
Syndrome diGeorge is associated amongst other clinical signs with various degrees of thymic dysplasia, related immunodeficiency and autoimmune disorders. Helios, a transcription factor from Ikaros family, has been proposed as a marker for thymus derived Tregs. We therefore examined Helios + Tregs in a cohort of patients with genetically proven diGeorge syndrome with typical T cell lymphopenia due to the thymic pathology.
Methods
T cells, FoxP3+ Tregs and Helios + FoxP3+ Tregs were examined in 52 samples from 37 patients. One patient with diGeorge/CHARGE syndrome with total thymic aplasia was also included. Statistical analysis was performed using a linear regression comparison.
Results
Total absolute Tregs were significantly lower in diGeorge patients as compared to controls in all age groups (0–20 years) (p = 0.0016). The difference was more expressed in the first four years of age. Relative Treg numbers expressed as the percentage of Tregs in CD4+ T-cells, however, were not different in patients and controls in all age groups (p = 0.661), neither could we find any significant difference in the percentage of Helios + Tregs between patients and controls (p = 0.238). Helios + Tregs were still present in a patient with diGeorge/CHARGE syndrome with complete athymia 7 years after partially matched unrelated repeated T lymphocytes infusions.
Conclusion
Our findings show that while there was a significant decrease in absolute numbers of Tregs in patients with diGeorge syndrome, the relative percentage of this population did not differ between patients and controls. Low absolute Tregs thus reflected typical T cells lymphopenia in patients. Helios expression was not affected in diGeorge syndrome.
Similar content being viewed by others
References
Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184:387–96.
Lin X, Chen M, Liu Y, Guo Z, He X, Brand D, et al. Advances in distinguishing natural from induced Foxp3 + regulatory T cells. Int J Clin Exp Pathol. 2013;6:116–23.
Apostolou I, Verginis P, Kretschmer K, Polansky J, Hühn J, von Boehmer H. Peripherally induced Treg: mode, stability, and role in specific tolerance. J Clin Immunol. 2008;28:619–24.
Dhamne C, Chung Y, Alousi AM, Cooper LJN, Tran DQ. Peripheral and thymic foxp3 (+) regulatory T cells in search of origin, distinction, and function. Front Immunol. 2013;4:253.
Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, Georgopoulos K, et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol. 1998;8:508–15.
Sugimoto N, Oida T, Hirota K, Nakamura K, Nomura T, Uchiyama T, et al. Foxp3-dependent and -independent molecules specific for CD25 + CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol. 2006;18:1197–209.
Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433–41.
DiGeorge AM, Lischner HW, Dacou C, Arey JB (1967) Absence of thymus. Lancet 289.
Halford S, Wadey R, Roberts C, Daw S, Whiting J, O’Donnell H, et al. Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet. 1993;2:2099–107.
Jongmans MCJ, Admiraal RJ, van der Donk KP, et al. Charge syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43:306–14.
de Lonlay-Debeney P, Cormier-Daire V, Amiel J, et al. Features of Di George syndrome and Charge association in five patients. J Med Genet. 1997;34:986–9.
Theodoropoulos DS. Immune deficiency in Charge association. Clin Med Res. 2003;1:43–8.
Gennery AR, Barge D, O’Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child. 2002;86:422–5.
Jawad AF, Prak EL, Boyer J, McDonald-McGinn DM, Zackai E, McDonald K, et al. A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome). J Clin Immunol. 2011;31:927–35.
Sullivan KE, Mcdonald-McGinn D, Zackai EH. CD4+ CD25+ T-Cell Production in Healthy Humans and in Patients with Thymic Hypoplasia. Clin Diagn Lab Immunol. 2002;9:1129–31.
Ferrando-Martínez S, Lorente R, Gurbindo D, De José MI, Leal M, Muñoz-Fernández MA, et al. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome. J Pediatr. 2014;164:882–9.
Janda A, Sedlacek P, Mejstrikova E, et al. Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatr Transplant. 2007;11:441–7.
Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS One. 2011;6:e24226.
Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK. Helios and Helios Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans. J Immunol. 2013;190:2001–8.
Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WCJ, Groeneveld K, et al. Immuno phenotyping of blood lymphocytes in childhood - Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.
Pongers-Willemse M. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia. 1998;12:2006–14.
Weinberg K. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458–66.
Van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJM. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204:645–55.
McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008;122:362–7.
Puck JM. The case for newborn screening for severe combined immunodeficiency and related disorders. Ann N Y Acad Sci. 2011;1246:108–17.
Lingman Framme J, Borte S, von Döbeln U, Hammarström L, Oskarsdóttir S. Retrospective Analysis of TREC Based Newborn Screening Results and Clinical Phenotypes in Infants with the 22q11 Deletion Syndrome. J Clin Immunol. 2014. doi:10.1007/s10875-014-0002-y.
Acknowledgments
This research was financially supported by the IGA MZ ČR NT 13287-4/2012 grant issued by the Czech Ministry of Health. We would like to thank MUDr. Tomáš Kalina, PhD for valuable help with the analysis of flow-cytometric data.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Online resource 1
(GIF 162 kb)
High resolution Image
(TIFF 838 kb)
Online resource 2
(GIF 17 kb)
High resolution Image
(TIFF 1492 kb)
Online resource 3
(GIF 1 kb)
High resolution Image
(TIFF 530 kb)
Online resource 4
(GIF 12 kb)
High resolution Image
(TIFF 1143 kb)
Online resource 5
(GIF 2 kb)
High resolution Image
(TIFF 924 kb)
Rights and permissions
About this article
Cite this article
Klocperk, A., Grecová, J., Šišmová, K. et al. Helios Expression in T-regulatory Cells in Patients with di George Syndrome. J Clin Immunol 34, 864–870 (2014). https://doi.org/10.1007/s10875-014-0071-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-014-0071-y